PER percheron therapeutics limited

Looks ok to me, given all that has gone down over the past six...

  1. 3,165 Posts.
    lightbulb Created with Sketch. 555
    Looks ok to me, given all that has gone down over the past six months!

    "The accompanying unaudited quarterly cash flow report suggests a figure of 2.9 quarters for the Company’s cash runway. This is calculated using cash on hand as at 31 March 2025, divided by cash outflows in the March quarter, as the Company is obliged to report. However, the Company expects that cash outflows in subsequent quarters will be significantly lower than the March quarter, particularly as the final wind-up of the phase IIb study in DMD is largely completed and given the cost reductions implemented during this period.
    The Company also anticipates receiving an R&D tax incentive payment in 2H CY2025. Based on the Company’s forward-looking cash flow forecasts, before any payments associated with in-licensing or developing a new asset, the Company expects runway comfortably into FY2027."

    GLTAH
    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.